| Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer J Atzpodien, H Kirchner, EL Hänninen, M Deckert, M Fenner, H Poliwoda European Journal of Cancer 29, S6-S8, 1993 | 196 | 1993 |
| Current constructs and targets in clinical development for antibody-based cancer therapy PM Deckert Current drug targets 10 (2), 158-175, 2009 | 129 | 2009 |
| Targeted enzyme prodrug therapies N Schellmann, PM Deckert, D Bachran, H Fuchs, C Bachran Mini reviews in medicinal chemistry 10 (10), 887-904, 2010 | 111 | 2010 |
| A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy PM Deckert, C Renner, LS Cohen, A Jungbluth, G Ritter, JR Bertino, ... British journal of cancer 88 (6), 937-939, 2003 | 66 | 2003 |
| European studies of interleukin-2 in metastatic renal cell carcinoma. J Atzpodien, H Kirchner, EL Hänninen, A Körfer, M Fenner, T Menzel, ... Seminars in oncology 20 (6 Suppl 9), 22-26, 1993 | 58 | 1993 |
| Pharmacokinetics and microdistribution of polyethylene glycol‐modified humanized A33 antibody targeting colon cancer xenografts PM Deckert, A Jungbluth, N Montalto, MA Clark, RD Finn, C Williams Jr, ... International journal of cancer 87 (3), 382-390, 2000 | 47 | 2000 |
| Design, construction, and in vitro analysis of A33scFv:: CDy, a recombinant fusion protein for antibody-directed enzyme prodrug therapy in colon cancer V Coelho, J Dernedde, U Petrausch, H Panjideh, H Fuchs, C Menzel, ... International journal of oncology 31 (4), 951-957, 2007 | 46 | 2007 |
| Expansion of Peripheral Blood Natural Killer Cells Correlates with Clinical Outcome in Cancer Patients Receiving Recombinant Subcutaneous lnterleukin-2 and Interferon-α-2 J Atzpodien, H Kirchner, A Körfer, M Hadam, A Schomburg, T Menzel, ... Tumor biology 14 (6), 354-359, 1993 | 41 | 1993 |
| Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients S Duensing, I Dallmann, J Grosse, J Buer, E Lopez Hänninen, M Deckert, ... Oncology 51 (4), 309-313, 1994 | 38 | 1994 |
| Diagnostic performance of contrast enhanced pulmonary computed tomography angiography for the detection of angioinvasive pulmonary aspergillosis in immunocompromised patients C Henzler, T Henzler, D Buchheidt, JW Nance, CA Weis, R Vogelmann, ... Scientific reports 7 (1), 4483, 2017 | 37 | 2017 |
| Ifosfamide/liposomal daunorubicin is a well tolerated and active first‐line chemotherapy regimen in advanced soft tissue sarcoma: Results of a Phase II study JM Siehl, E Thiel, A Schmittel, G Hütter, PM Deckert, H Szelényi, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 34 | 2005 |
| Specific tumour localisation of a huA33 antibody-carboxypeptidase A conjugate and activation of methotrexate-phenylalanine PM Deckert, WG Bornmann, G Ritter, C Williams, J Franke, U Keilholz, ... International journal of oncology 24 (5), 1289-1295, 2004 | 30 | 2004 |
| Biodistribution and efficacy of [131I] A33scFv:: CDy, a recombinant antibody-enzyme protein for colon cancer H Panjideh, VC Da Silva Coelho, J Dernedde, C Bachran, GJ Förster, ... International journal of oncology 32 (4), 925-930, 2008 | 24 | 2008 |
| A33scFv–Green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting U Petrausch, J Dernedde, V Coelho, H Panjideh, D Frey, H Fuchs, E Thiel, ... Protein Engineering, Design & Selection 20 (12), 583-590, 2007 | 24 | 2007 |
| CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. PM Deckert, M Ballmaier, S Lang, H Deicher, I Schedel Journal of immunology (Baltimore, Md.: 1950) 156 (2), 826-833, 1996 | 23 | 1996 |
| Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatants H Panjideh, V Coelho, J Dernedde, H Fuchs, U Keilholz, E Thiel, ... Bioprocess and Biosystems Engineering 31, 559-568, 2008 | 18 | 2008 |
| Molecular biomarkers of DNA damage in diffuse large-cell lymphoma—a review M Ruhe, D Rabe, C Jurischka, J Schröder, P Schierack, PM Deckert, ... Journal of Laboratory and Precision Medicine 4, 2019 | 13 | 2019 |
| In vivo time and dose dependency of interleukin-6 secretion in response to low-dose subcutaneous recombinant interleukin-2 M Meffert, EL Hanninen, T Menzel, A Schomburg, S Duensing, I Dallmann, ... Cancer Biotherapy & Radiopharmaceuticals 9 (4), 307-316, 1994 | 13 | 1994 |
| Treatment of Metastatic Colorectal Cancer Patients with 5-Fluorouracil in Combination with Recombinant Subcutaneous Human lnterleukin-2 and Alpha-lnterferon J Atzpodien, H Kirchner, EL Hänninen, T Menzel, M Deckert, A Franzke, ... Oncology 51 (3), 273-275, 1994 | 10 | 1994 |
| Surface expression of gpA33 is dependent on culture density and cell-cycle phase and is regulated by intracellular traffic rather than gene transcription D Frey, V Coelho, U Petrausch, M Schaefer, U Keilholz, E Thiel, ... Cancer biotherapy & radiopharmaceuticals 23 (1), 65-73, 2008 | 9 | 2008 |
Stefan RödigerBTU Cottbus - Senftenberg在 b-tu.de 的电子邮件经过验证
